The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

Inverse correlation seen for arterial flow mediated dilation with smoking frequency and amount of THC ingested.

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

Patients who would benefit most from surgery and are least likely to benefit from continued medical therapy alone should be identified ...

It's not likely that shoppers will come across any fresh tomatoes from the recalled batch, according to the FDA.

Clinically relevant but not statistically significant improvement seen in anxiety and fatigue versus usual services.

A phase 1 trial, LUMINA, is currently underway and is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMX0114 in approximately 48 patients with ALS.

Most pushback due to child expectations of vaccine-free visit at 9 years; discussions shorter since sexual activity not perceived as salient.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis ...

The discovery evidence in this case, particularly the deposition evidence, made it clear that the plaintiff had a strong case against the hospital.

The Food and Drug Administration (FDA) has approved Khindivi ™ (hydrocortisone) oral solution as a replacement therapy in ...